Cargando…

Inhibition of the NLRP3-inflammasome prevents cognitive deficits in experimental autoimmune encephalomyelitis mice via the alteration of astrocyte phenotype

Multiple sclerosis (MS) is a chronic disease that is characterized by demyelination and axonal damage in the central nervous system. Cognitive deficits are recognized as one of the features of MS, and these deficits affect the patients’ quality of life. Increasing evidence from experimental autoimmu...

Descripción completa

Detalles Bibliográficos
Autores principales: Hou, Baohua, Zhang, Yahui, Liang, Peiyu, He, Yuan, Peng, Biwen, Liu, Wanhong, Han, Song, Yin, Jun, He, Xiaohua
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7229224/
https://www.ncbi.nlm.nih.gov/pubmed/32415059
http://dx.doi.org/10.1038/s41419-020-2565-2
_version_ 1783534718793285632
author Hou, Baohua
Zhang, Yahui
Liang, Peiyu
He, Yuan
Peng, Biwen
Liu, Wanhong
Han, Song
Yin, Jun
He, Xiaohua
author_facet Hou, Baohua
Zhang, Yahui
Liang, Peiyu
He, Yuan
Peng, Biwen
Liu, Wanhong
Han, Song
Yin, Jun
He, Xiaohua
author_sort Hou, Baohua
collection PubMed
description Multiple sclerosis (MS) is a chronic disease that is characterized by demyelination and axonal damage in the central nervous system. Cognitive deficits are recognized as one of the features of MS, and these deficits affect the patients’ quality of life. Increasing evidence from experimental autoimmune encephalomyelitis (EAE), the animal model of MS, has suggested that EAE mice exhibit hippocampal impairment and cognitive deficits. However, the underlying mechanisms are still unclear. The NLRP3 inflammasome is a key contributor to neuroinflammation and is involved in the development of MS and EAE. Activation of the NLRP3 inflammasome in microglia is fundamental for subsequent inflammatory events. Activated microglia can convert astrocytes to the neurotoxic A1 phenotype in a variety of neurological diseases. However, it remains unknown whether the NLRP3 inflammasome contributes to cognitive deficits and astrocyte phenotype alteration in EAE. In this study, we demonstrated that severe memory deficits occurred in the late phase of EAE, and cognitive deficits were ameliorated by treatment with MCC950, an inhibitor of the NLRP3 inflammasome. In addition, MCC950 alleviated hippocampal pathology and synapse loss. Astrocytes from EAE mice were converted to the neurotoxic A1 phenotype, and this conversion was prevented by MCC950 treatment. IL-18, which is the downstream of NLRP3 inflammasome, was sufficient to induce the conversion of astrocytes to the A1 phenotype through the NF-κB pathway. IL-18 induced A1 type reactive astrocytes impaired hippocampal neurons through the release of complement component 3 (C3). Altogether, our present data suggest that the NLRP3 inflammasome plays an important role in cognitive deficits in EAE, possibly via the alteration of astrocyte phenotypes. Our study provides a novel therapeutic strategy for hippocampal impairment in EAE and MS.
format Online
Article
Text
id pubmed-7229224
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-72292242020-05-18 Inhibition of the NLRP3-inflammasome prevents cognitive deficits in experimental autoimmune encephalomyelitis mice via the alteration of astrocyte phenotype Hou, Baohua Zhang, Yahui Liang, Peiyu He, Yuan Peng, Biwen Liu, Wanhong Han, Song Yin, Jun He, Xiaohua Cell Death Dis Article Multiple sclerosis (MS) is a chronic disease that is characterized by demyelination and axonal damage in the central nervous system. Cognitive deficits are recognized as one of the features of MS, and these deficits affect the patients’ quality of life. Increasing evidence from experimental autoimmune encephalomyelitis (EAE), the animal model of MS, has suggested that EAE mice exhibit hippocampal impairment and cognitive deficits. However, the underlying mechanisms are still unclear. The NLRP3 inflammasome is a key contributor to neuroinflammation and is involved in the development of MS and EAE. Activation of the NLRP3 inflammasome in microglia is fundamental for subsequent inflammatory events. Activated microglia can convert astrocytes to the neurotoxic A1 phenotype in a variety of neurological diseases. However, it remains unknown whether the NLRP3 inflammasome contributes to cognitive deficits and astrocyte phenotype alteration in EAE. In this study, we demonstrated that severe memory deficits occurred in the late phase of EAE, and cognitive deficits were ameliorated by treatment with MCC950, an inhibitor of the NLRP3 inflammasome. In addition, MCC950 alleviated hippocampal pathology and synapse loss. Astrocytes from EAE mice were converted to the neurotoxic A1 phenotype, and this conversion was prevented by MCC950 treatment. IL-18, which is the downstream of NLRP3 inflammasome, was sufficient to induce the conversion of astrocytes to the A1 phenotype through the NF-κB pathway. IL-18 induced A1 type reactive astrocytes impaired hippocampal neurons through the release of complement component 3 (C3). Altogether, our present data suggest that the NLRP3 inflammasome plays an important role in cognitive deficits in EAE, possibly via the alteration of astrocyte phenotypes. Our study provides a novel therapeutic strategy for hippocampal impairment in EAE and MS. Nature Publishing Group UK 2020-05-15 /pmc/articles/PMC7229224/ /pubmed/32415059 http://dx.doi.org/10.1038/s41419-020-2565-2 Text en © The Author(s) 2020 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
spellingShingle Article
Hou, Baohua
Zhang, Yahui
Liang, Peiyu
He, Yuan
Peng, Biwen
Liu, Wanhong
Han, Song
Yin, Jun
He, Xiaohua
Inhibition of the NLRP3-inflammasome prevents cognitive deficits in experimental autoimmune encephalomyelitis mice via the alteration of astrocyte phenotype
title Inhibition of the NLRP3-inflammasome prevents cognitive deficits in experimental autoimmune encephalomyelitis mice via the alteration of astrocyte phenotype
title_full Inhibition of the NLRP3-inflammasome prevents cognitive deficits in experimental autoimmune encephalomyelitis mice via the alteration of astrocyte phenotype
title_fullStr Inhibition of the NLRP3-inflammasome prevents cognitive deficits in experimental autoimmune encephalomyelitis mice via the alteration of astrocyte phenotype
title_full_unstemmed Inhibition of the NLRP3-inflammasome prevents cognitive deficits in experimental autoimmune encephalomyelitis mice via the alteration of astrocyte phenotype
title_short Inhibition of the NLRP3-inflammasome prevents cognitive deficits in experimental autoimmune encephalomyelitis mice via the alteration of astrocyte phenotype
title_sort inhibition of the nlrp3-inflammasome prevents cognitive deficits in experimental autoimmune encephalomyelitis mice via the alteration of astrocyte phenotype
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7229224/
https://www.ncbi.nlm.nih.gov/pubmed/32415059
http://dx.doi.org/10.1038/s41419-020-2565-2
work_keys_str_mv AT houbaohua inhibitionofthenlrp3inflammasomepreventscognitivedeficitsinexperimentalautoimmuneencephalomyelitismiceviathealterationofastrocytephenotype
AT zhangyahui inhibitionofthenlrp3inflammasomepreventscognitivedeficitsinexperimentalautoimmuneencephalomyelitismiceviathealterationofastrocytephenotype
AT liangpeiyu inhibitionofthenlrp3inflammasomepreventscognitivedeficitsinexperimentalautoimmuneencephalomyelitismiceviathealterationofastrocytephenotype
AT heyuan inhibitionofthenlrp3inflammasomepreventscognitivedeficitsinexperimentalautoimmuneencephalomyelitismiceviathealterationofastrocytephenotype
AT pengbiwen inhibitionofthenlrp3inflammasomepreventscognitivedeficitsinexperimentalautoimmuneencephalomyelitismiceviathealterationofastrocytephenotype
AT liuwanhong inhibitionofthenlrp3inflammasomepreventscognitivedeficitsinexperimentalautoimmuneencephalomyelitismiceviathealterationofastrocytephenotype
AT hansong inhibitionofthenlrp3inflammasomepreventscognitivedeficitsinexperimentalautoimmuneencephalomyelitismiceviathealterationofastrocytephenotype
AT yinjun inhibitionofthenlrp3inflammasomepreventscognitivedeficitsinexperimentalautoimmuneencephalomyelitismiceviathealterationofastrocytephenotype
AT hexiaohua inhibitionofthenlrp3inflammasomepreventscognitivedeficitsinexperimentalautoimmuneencephalomyelitismiceviathealterationofastrocytephenotype